We are currently living in the “golden age” of biotechnology. Scientific advances have created new ways to treat and prevent diseases that were previously only thought possible by imagination alone. The biotech sector is also presenting exciting opportunities for investors, as companies with both strong drug candidate pipelines and winning drugs already on the market […]